Onderneming BioRestorative Therapies, Inc. Other OTC
Aandelen
BRTX
US0906554086
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutic Products and Medical Therapies
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +21,70% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +21,70% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lance Alstodt
CEO | Chief Executive Officer | 53 | 01-10-18 |
Robert Kristal
DFI | Director of Finance/CFO | - | 04-11-21 |
Compliance Officer | 55 | 01-09-15 | |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 13-04-11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Patrick Williams
BRD | Director/Board Member | 51 | 29-10-21 |
David Rosa
BRD | Director/Board Member | 59 | 29-10-21 |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 13-04-11 |
Nickolay Kukekov
BRD | Director/Board Member | 49 | 18-03-21 |
Lance Alstodt
CEO | Chief Executive Officer | 53 | 01-10-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 1 398 158 | 0 | 0 | 81,20 % |
Aandeel B | 1 | 6 769 919 | 5 497 141 ( 81,20 %) | 0 |
Bedrijfsgegevens
BioRestorative Therapies, Inc.
40 Marcus Drive Suite 1
11747, Melville
+631 760 8100
http://www.biorestorative.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,15% | 103 mld. | |
+8,38% | 101 mld. | |
+4,40% | 23,07 mld. | |
-12,02% | 22,23 mld. | |
-4,36% | 18,05 mld. | |
-39,98% | 17,18 mld. | |
-10,33% | 16,94 mld. | |
+6,60% | 14,07 mld. | |
+39,21% | 12,35 mld. |